vs
Side-by-side financial comparison of Arbutus Biopharma Corp (ABUS) and GOLDEN HEAVEN GROUP HOLDINGS LTD. (GDHG). Click either name above to swap in a different company.
GOLDEN HEAVEN GROUP HOLDINGS LTD. is the larger business by last-quarter revenue ($15.3M vs $10.7M, roughly 1.4× Arbutus Biopharma Corp). Arbutus Biopharma Corp runs the higher net margin — 23.5% vs -56.2%, a 79.7% gap on every dollar of revenue.
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
Golden Heaven Group Holdings Ltd. operates large-scale amusement parks, cultural tourism complexes and family-focused leisure venues primarily across mainland China. Its core services include thrill rides, themed entertainment zones, cultural experience activities, plus supporting catering and retail offerings, catering to leisure demands of consumers across all age groups.
ABUS vs GDHG — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $10.7M | $15.3M |
| Net Profit | $2.5M | $-8.6M |
| Gross Margin | — | 50.2% |
| Operating Margin | 13.9% | -44.5% |
| Net Margin | 23.5% | -56.2% |
| Revenue YoY | 522.2% | — |
| Net Profit YoY | 112.7% | — |
| EPS (diluted) | $0.01 | $-10.83 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $15.3M | ||
| Q2 25 | $10.7M | — | ||
| Q1 25 | — | $13.8M | ||
| Q1 24 | — | $13.8M | ||
| Q4 23 | $2.1M | — | ||
| Q3 23 | $4.7M | — | ||
| Q2 23 | $4.7M | — | ||
| Q1 23 | $6.7M | — |
| Q3 25 | — | $-8.6M | ||
| Q2 25 | $2.5M | — | ||
| Q1 25 | — | — | ||
| Q1 24 | — | $2.5M | ||
| Q4 23 | — | — | ||
| Q3 23 | $-20.1M | — | ||
| Q2 23 | $-17.1M | — | ||
| Q1 23 | $-16.3M | — |
| Q3 25 | — | 50.2% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 52.0% | ||
| Q1 24 | — | 52.0% | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — |
| Q3 25 | — | -44.5% | ||
| Q2 25 | 13.9% | — | ||
| Q1 25 | — | — | ||
| Q1 24 | — | 25.5% | ||
| Q4 23 | -967.2% | — | ||
| Q3 23 | -462.8% | — | ||
| Q2 23 | -395.3% | — | ||
| Q1 23 | -260.4% | — |
| Q3 25 | — | -56.2% | ||
| Q2 25 | 23.5% | — | ||
| Q1 25 | — | — | ||
| Q1 24 | — | 18.4% | ||
| Q4 23 | — | — | ||
| Q3 23 | -431.6% | — | ||
| Q2 23 | -367.5% | — | ||
| Q1 23 | -244.3% | — |
| Q3 25 | — | $-10.83 | ||
| Q2 25 | $0.01 | — | ||
| Q1 25 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | $-0.12 | — | ||
| Q3 23 | $-0.12 | — | ||
| Q2 23 | $-0.10 | — | ||
| Q1 23 | $-0.10 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $37.4M | $86.0M |
| Total DebtLower is stronger | $0 | — |
| Stockholders' EquityBook value | $83.0M | $180.7M |
| Total Assets | $103.3M | $191.4M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $86.0M | ||
| Q2 25 | $37.4M | — | ||
| Q1 25 | — | $19.8M | ||
| Q1 24 | — | $129.4K | ||
| Q4 23 | $126.0M | — | ||
| Q3 23 | $17.5M | — | ||
| Q2 23 | $27.2M | — | ||
| Q1 23 | $40.6M | — |
| Q3 25 | — | — | ||
| Q2 25 | $0 | — | ||
| Q1 25 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | $0 | — | ||
| Q3 23 | $0 | — | ||
| Q2 23 | $0 | — | ||
| Q1 23 | $0 | — |
| Q3 25 | — | $180.7M | ||
| Q2 25 | $83.0M | — | ||
| Q1 25 | — | $83.7M | ||
| Q1 24 | — | $64.3M | ||
| Q4 23 | $106.0M | — | ||
| Q3 23 | $119.3M | — | ||
| Q2 23 | $134.7M | — | ||
| Q1 23 | $143.9M | — |
| Q3 25 | — | $191.4M | ||
| Q2 25 | $103.3M | — | ||
| Q1 25 | — | $98.6M | ||
| Q1 24 | — | $82.9M | ||
| Q4 23 | $144.4M | — | ||
| Q3 23 | $158.6M | — | ||
| Q2 23 | $176.8M | — | ||
| Q1 23 | $191.2M | — |
| Q3 25 | — | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | 0.00× | — | ||
| Q3 23 | 0.00× | — | ||
| Q2 23 | 0.00× | — | ||
| Q1 23 | 0.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-15.7M | $19.0M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | -6.24× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $19.0M | ||
| Q2 25 | $-15.7M | — | ||
| Q1 25 | — | — | ||
| Q1 24 | — | $-911.6K | ||
| Q4 23 | $-17.3M | — | ||
| Q3 23 | $-21.8M | — | ||
| Q2 23 | $-19.6M | — | ||
| Q1 23 | $-27.3M | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q1 24 | — | $-924.9K | ||
| Q4 23 | — | — | ||
| Q3 23 | $-21.8M | — | ||
| Q2 23 | $-20.4M | — | ||
| Q1 23 | $-27.4M | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q1 24 | — | -6.7% | ||
| Q4 23 | — | — | ||
| Q3 23 | -468.4% | — | ||
| Q2 23 | -439.0% | — | ||
| Q1 23 | -410.0% | — |
| Q3 25 | — | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | — | — | ||
| Q1 24 | — | 0.1% | ||
| Q4 23 | 0.0% | — | ||
| Q3 23 | 0.7% | — | ||
| Q2 23 | 18.5% | — | ||
| Q1 23 | 1.7% | — |
| Q3 25 | — | — | ||
| Q2 25 | -6.24× | — | ||
| Q1 25 | — | — | ||
| Q1 24 | — | -0.36× | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
